10/29/2024SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024 (with Annual M...

10/29/2024Nine Pharma MNCs Grew Their Combined China Revenue at 12.5% CAGR betwe...

10/29/2024GSK Acquires CMG1A46 from Chimagen Biosciences to Expand Immunology P...

10/29/2024Innovative Drugs Lead the 2024 Health Insurance Price Negotiations in ...

10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...

10/28/2024China Expands Contract Manufacturing for Biopharmaceuticals in New Pil...

10/28/2024China Begins 2024 NRDL Negotiations with Key Focus on Innovation and P...

10/25/2024China and Denmark Strengthen Collaboration in Pharmaceutical and Medic...

10/25/2024Data Review: Chinese Drug Market 2016-2023

10/25/2024Recent Executive Moves

10/24/2024Hope Medicine Announces Positive Results from a Global Phase 2 Study o...

10/24/2024Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...

10/24/2024NHSA to Initiate New Round of Negotiation for 2024 NRDL Listing

10/24/2024Reinventing Your China Strategy: A Podcast Preview of the China Health...

10/23/2024Guangzhou Aims to Establish Itself as a Global Biopharmaceutical Hub

10/23/2024China Recovers CNY 16B in Misused BMI Funds

10/22/2024Bristol Ends LaNova Partnership on Claudin18.2 ADC, Eyes Potential I-M...

10/22/2024XellSmart RaisesCNY 100M+ in Series B1 Financing for iPS-Derived Cell ...

10/21/2024Akeso Launches Phase 1/2 Trial for Novel Bispecific Antibody Combinati...

10/21/2024BeiGene's Secures 14th Indication in China for Tislelizumab

10/21/2024NMPA Issues the Pilot Plan for Staged Production of Biological Product...

10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...

10/18/2024AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...

10/18/2024NMPA Launches Pilot Reform for Staged Production of Biologicals

10/18/2024Recent Executive Moves

10/17/2024MSD Files NDA for WINREVAIR (sotatercept) in China

10/17/2024China Initiates Data Collection for the 10th Round of the National Lev...

10/17/2024Hutchmed Announces Positive Results from Phase II SAVANNAH Trial for L...

10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...

10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab

Page:16/354 Total number of articles:10618: [First][<<] [14] [15] [16] [17] [18] [>>] [End]